SS Innovations International (SSII) Non-Current Deffered Revenue (2022 - 2026)
SS Innovations International's (SSII) quarterly Non-Current Deffered Revenue came in at $8.7 million in Q2 2026, up 50.46% year-over-year from $5.8 million in Q2 2025, and up 15.92% quarter-over-quarter from $7.5 million in Q1 2026.
Analysis
SS Innovations International (SSII) Non-Current Deffered Revenue (2022 - 2026) Analysis & Trends
SS Innovations International has disclosed Non-Current Deffered Revenue across 5 years of filings, most recently posting $8.7 million for Q2 2026.
- In Q2 2026, Non-Current Deffered Revenue rose 50.46% year-over-year to $8.7 million; the TTM figure through Jun 2026 stood at $8.7 million (up 50.46% YoY), while the FY2025 annual figure was $7.1 million, up 38.0% from the prior year.
- Non-Current Deffered Revenue came in at $8.7 million for Q2 2026 at SS Innovations International, up from $7.5 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $8.7 million in Q2 2026 to a low of $42141.0 in Q4 2022.
- Average Non-Current Deffered Revenue over 5 years is $4.2 million, with a median of $4.7 million recorded in 2024.
- Year-over-year, Non-Current Deffered Revenue soared 2128.59% in 2023 and soared 38.0% in 2025.
- Over 5 years, Non-Current Deffered Revenue stood at $42141.0 in 2022, then soared by 2128.59% to $939150.0 in 2023, then surged by 450.92% to $5.2 million in 2024, then jumped by 38.0% to $7.1 million in 2025, then increased by 21.79% to $8.7 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $8.7 million in Q2 2026, $7.5 million in Q1 2026, and $7.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | - |
| 10 | SS Innovations International | 682.58 Mn | 660.28 Mn | 7.10 Mn | 8.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.70 Mn |
| Mar 31, 2026 | 7.50 Mn |
| Dec 31, 2025 | 7.14 Mn |
| Sep 30, 2025 | 6.28 Mn |
| Jun 30, 2025 | 5.78 Mn |
| Mar 31, 2025 | 5.41 Mn |
| Dec 31, 2024 | 5.17 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.13 Mn |
| Dec 31, 2023 | 939,150.00 |
| Sep 30, 2023 | 796,235.00 |
| Jun 30, 2023 | 348,993.00 |
| Dec 31, 2022 | 42,141.00 |